NDC 70510-2171

RADICAVA

Edaravone

RADICAVA is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Mitsubishi Tanabe Pharma America, Inc.. The primary component is Edaravone.

Product ID70510-2171_26a8730f-518e-40d1-b695-536526c6a87b
NDC70510-2171
Product TypeHuman Prescription Drug
Proprietary NameRADICAVA
Generic NameEdaravone
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2017-05-05
Marketing CategoryNDA / NDA
Application NumberNDA209176
Labeler NameMitsubishi Tanabe Pharma America, Inc.
Substance NameEDARAVONE
Active Ingredient Strength30 mg/100mL
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 70510-2171-2

2 BAG in 1 CARTON (70510-2171-2) > 100 mL in 1 BAG (70510-2171-1)
Marketing Start Date2017-05-05
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70510-2171-2 [70510217102]

RADICAVA INJECTION
Marketing CategoryNDA
Application NumberNDA209176
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2017-05-05
Inactivation Date2020-01-31
Reactivation Date2020-03-12

NDC 70510-2171-1 [70510217101]

RADICAVA INJECTION
Marketing CategoryNDA
Application NumberNDA209176
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2017-05-05

NDC 70510-2171-0 [70510217100]

RADICAVA INJECTION
Marketing CategoryNDA
Application NumberNDA209176
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-05-05
Marketing End Date2017-11-14

Drug Details

Active Ingredients

IngredientStrength
EDARAVONE30 mg/100mL

NDC Crossover Matching brand name "RADICAVA" or generic name "Edaravone"

NDCBrand NameGeneric Name
70510-2171RADICAVAEDARAVONE
70510-2172RADICAVAedaravone
70510-2321RADICAVA ORSEDARAVONE
70510-2322RADICAVA ORSEDARAVONE

Trademark Results [RADICAVA]

Mark Image

Registration | Serial
Company
Trademark
Application Date
RADICAVA
RADICAVA
87132086 5387607 Live/Registered
Mitsubishi Tanabe Pharma Corporation
2016-08-09
RADICAVA
RADICAVA
86863296 5277200 Live/Registered
Mitsubishi Tanabe Pharma Corporation
2015-12-31

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.